Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.
PINPOINT
2 other identifiers
interventional
20
1 country
2
Brief Summary
Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes
Started Mar 2026
Shorter than P25 for not_applicable diabetes
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2026
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 24, 2026
January 20, 2026
January 1, 2026
6 months
January 16, 2026
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cervical cancer screening
receiving cervical cancer screening either via self-collection, pap smear, or hpv testing
within 6 months
Secondary Outcomes (3)
Acceptability
from enrollment until they complete screening or at the end of the trial at 6 months
Appropriateness
from enrollment until they complete screening or at the end of the trial at 6 months
Feasibility measure
from enrollment until they complete screening or at the end of the trial at 6 months
Study Arms (2)
Intervention
EXPERIMENTALPINPOINT intervention arm will entail assigning patients to a patient navigator to assist them with screening reminders and address any barriers they have to screening, education on cervical cancer screening, and patients will also be offered the opportunity to self-collect their sample for cervical cancer screening.
Control Arm
NO INTERVENTIONNo intervention arm, patients will receive reminders for screening according to current clinical practice
Interventions
Patients will receive a combination of patient navigation, education, and cervical cancer self-collection sampling as part of the intervention to support cervical cancer screening.
Eligibility Criteria
You may qualify if:
- Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible
- Active UF Internal Medicine patient and has had an appointment in the last 2 months.
- Assigned sex at birth is female
- Have Obesity or Type 2 Diabetes
- Not currently pregnant (self-report)
- Have not given birth in the prior 12 weeks
- No previous history of cervical cancer
- No previous history of a hysterectomy
- Have not undergone cancer screening in the past 3 years or more
- Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County).
- Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address.
- Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear).
You may not qualify if:
- Previous history of cervical cancer
- Total hysterectomy
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- National Cancer Institute (NCI)collaborator
Study Sites (2)
UF Health Internal Medicine
Gainesville, Florida, 32611, United States
University of Florida
Gainesville, Florida, 32611, United States
Related Publications (3)
Mkuu RS, Staras SA, Szurek SM, D'Ingeo D, Gerend MA, Goede DL, Shenkman EA. Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study. BMC Cancer. 2022 Mar 9;22(1):252. doi: 10.1186/s12885-022-09350-5.
PMID: 35264120BACKGROUNDMkuu RS, Tohme S, Rivero-Mendoza D, Salloum RG, Goede D, Bruggeman B, Nicholson K, Hall JM, Bylund C, Woodard JN, Hensley J, Shenkman EA, Donahoo WT, Mulugeta A, Hernandez M, Staras SA. Improving Patient Education Materials for HPV Self-Collection: Insights from Women at High Risk of Developing Cervical Cancer. Cancer Manag Res. 2025 Dec 24;17:3273-3284. doi: 10.2147/CMAR.S552282. eCollection 2025.
PMID: 41467104BACKGROUNDMkuu RS, Staras SA, Chakrabarti C, Hall J, Harvey I, Salloum RG, Barrow S, Ortega S, Woodard J, Seals K, Rawls A, Meduri Y, Donahoo WT, Goede DL, Shenkman EA. Acceptability of HPV self-collection: A qualitative study of Black women living with type II diabetes and social vulnerability. J Clin Transl Endocrinol. 2024 Feb 25;35:100331. doi: 10.1016/j.jcte.2024.100331. eCollection 2024 Mar.
PMID: 38444842BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2026
First Posted
January 20, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
December 24, 2026
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Deidentified data will be available after the results of the study are published.